Posted: November 29, 2007

Global Market for Nanoparticles in Biomedical, Pharmaceutical and Cosmetic Applications Worth $204.6 Million in 2007

(Nanowerk News) According to a new technical market research report, NANOSTRUCTURED MATERIALS FOR THE BIOMEDICAL, PHARMACEUTICAL & COSMETIC MARKETS (NAN017D) from BCC Research (, the global market for nanoparticles in biomedical, pharmaceutical and cosmetic applications will be worth $204.6 million in 2007. This is expected to increase to over $684.4 million by 2012, a compound average annual growth rate (CAGR) of 27.3%.
The market is broken down into applications of biomedical, pharmaceutical and cosmetic applications. Of these, biomedical applications hold the largest share of the market. Worth an estimated $129.5 million in 2007, this segment is expected to be worth $519.5 million in 2012, a CAGR of 32.0%.
The second largest segment, cosmetic applications, was worth an estimated $72.2 million in 2007 and will reach $155.8 million by 2012. Pharmaceutical is currently a $2.9 million sector that will be worth $9.1 million in 2012, a CAGR of 25.7%.
Within these three broad application segments, three specific applications stand out: biodetection and labeling, orthopedic and dental applications, and sunscreens. Despite impressive growth rates in some other applications, these three applications are expected to account for more than 95% of the market in 2012.
The market is similarly concentrated in terms of material types. Four types of nanoparticles (gold, titanium dioxide, zinc oxide, and calcium phosphate) accounted for more than 90% of the market in 2006. Semiconductor nanoparticles (quantum dots), which accounted for a relatively small share of the market in 2006, are expected to capture 23% of the market by 2012, a share second only to calcium phosphate.
Source: BCC Research
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: